Wollongong patients involved in Keytruda trial

LW
Updated September 26 2018 - 8:05pm, first published 7:30pm
Gamechanging: Associate Professor Ali Tafreshi in his rooms at Wollongong Private Hospital with a vial of the drug Keytruda that he's using in trials for lung cancer patients. Picture: Adam McLean
Gamechanging: Associate Professor Ali Tafreshi in his rooms at Wollongong Private Hospital with a vial of the drug Keytruda that he's using in trials for lung cancer patients. Picture: Adam McLean

South Coast terminal lung cancer patients have been involved in a “practice-changing” clinical trial that has been shown to significantly prolong survival rates.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options
LW

Lisa Wachsmuth

Deputy Editor

Deputy editor and health reporter at the Illawarra Mercury, covering stories in the Wollongong, Shellharbour and Kiama local government areas. For news tips email lwachsmuth@austcommunitymedia.com.au

Get the latest Wollongong news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.